SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹9.35 Cr | ₹25 Cr | ₹23 Cr | ₹26 Cr | ₹12 Cr |
What is the latest Total Non-Current Liabilities ratio of SYSCHEM (INDIA) ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹9.35 Cr |
Mar2023 | ₹25 Cr |
Mar2022 | ₹23 Cr |
Mar2021 | ₹26 Cr |
Mar2020 | ₹12 Cr |
How is Total Non-Current Liabilities of SYSCHEM (INDIA) Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹9.35 Cr | -62.79 | |
Mar2023 | ₹25 Cr | 7.46 | |
Mar2022 | ₹23 Cr | -8.93 | |
Mar2021 | ₹26 Cr | 112.61 | |
Mar2020 | ₹12 Cr | - |
Compare Total Non-Current Liabilities of peers of SYSCHEM (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYSCHEM (INDIA) | ₹183.2 Cr | 15.3% | 8.9% | -37.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
SYSCHEM (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYSCHEM (INDIA) | 15.3% |
8.9% |
-37.5% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses